Avidity Partners Management’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Avidity Partners Management’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57,770	Closed	-$5.2K	–	105
2022 Q4	$5.2K	Hold	57,770	–	–	﹤0.01%	85
2022 Q3	$1K	Hold	57,770	–	–	﹤0.01%	97
2022 Q2	$10K	Hold	57,770	–	–	﹤0.01%	82
2022 Q1	$25K	Hold	57,770	–	–	﹤0.01%	92
2021 Q4	$42K	Hold	57,770	–	–	﹤0.01%	97
2021 Q3	$41K	Hold	57,770	–	–	﹤0.01%	105
2021 Q2	$58K	Buy	+57,770	New	+$45.8K	﹤0.01%	112

Avidity Partners Management's MSACW Position: Q1 2023 in Review

Avidity Partners Management sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 57,770 shares — an estimated $5.2K sold.

Avidity Partners Management first reported a position in MSACW in Q2 2021 and held it in 7 quarters. The position peaked at $58K in Q2 2021. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

Avidity Partners Management reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Avidity Partners Management sold 57,770 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $5.2K.
Avidity Partners Management first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
Avidity Partners Management's Medicus Sciences Acquisition Corp. Warrant position peaked at $58K in Q2 2021.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Avidity Partners Management's 13F filing for Q1 2023, filed 15 May 2023.